17/02/2017 17:45:00

Aerojet Rocketdyne Names John Schneider VP of Quality & Mission Assurance

Related content
25 Jul - 
Aerojet Rocketdyne’s RS-25 Flight Controller Goes Three..
06 Jul - 
Aerojet Rocketdyne Successfully Tests Advanced Electric..
29 Jun - 
Aerojet Rocketdyne Advocates Solar Electric Propulsion ..

SACRAMENTO, Calif., Feb. 17, 2017 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne, a subsidiary of Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD), today announced that John Schneider has been appointed vice president of Quality & Mission Assurance (Q&MA). He succeeds Jerry Tarnacki who was recently named senior vice president of the company’s Space Business Unit.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/75ca9ffa-0689-4347-ada8-635e58904b2b

Schneider joined Aerojet Rocketdyne in July 1988 and has served in a variety of leadership positions over the last 28 years, most recently as site director for the Los Angeles facility since December 2013.

In his new role as vice president of Q&MA, Schneider will report directly to Chief Operating Officer Mark Tucker and will work closely with Aerojet Rocketdyne’s 14 sites and various Space and Defense programs to drive continued implementation of the company’s new operating system, build on the company’s culture of quality, and improve Q&MA systems and processes across the enterprise.

“John’s exceptional attention to detail and his vast experience in operations and quality leadership make him a natural fit for this new role,” said Tucker. “John has continuously instilled a ‘value added’ culture within the organization, resulting in demonstrated success in fulfilling customer expectations and driving performance goals.”

Schneider holds a Bachelor of Science in Mechanical Engineering from Georgia Institute of Technology, and serves on the board of directors for the Aerojet Rocketdyne Foundation.

Aerojet Rocketdyne is an innovative company delivering solutions that create value for its customers in the aerospace and defense markets. The company is a world-recognized aerospace and defense leader that provides propulsion and energetics to the space, missile defense and strategic systems, tactical systems and armaments areas, in support of domestic and international markets. Additional information about Aerojet Rocketdyne can be obtained by visiting our websites at www.Rocket.com and www.AerojetRocketdyne.com.

Contact:

Glenn Mahone, Aerojet Rocketdyne, 202-302-9941

Glenn.Mahone@Rocket.com

Lynn Machon, Aerojet Rocketdyne, 916-355-3587

Lynn.Machon@Rocket.com

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Alliance Trust PLC : Transaction in Own Shares

26/07/2017 07:00:05
26 July 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 25 July 2017 the Company purchased for cancellation 100,000 ordinary shares of 2.5p each at a price of 716.5p per share.  Therefore, the total number of voting rights in the Company is now 352,188,122.    The above figure (352,188,122) may be used by shareholders a..

Alliance Trust PLC : Net Asset Value(s)

25/07/2017 14:52:29
ALLIANCE TRUST PLC                                    At the close of business on Monday 24 July 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 757.0p -       including income, 765.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income,..

Novae Group plc: Holdings in Company

25/07/2017 13:01:24
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ATOS : First half 2017 results
2
WORLDLINE SA : First half 2017 results
3
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
4
Outokumpu - Solid profitability despite ferrochrome production challenges, Group adjusted EBITDA at EUR 199 million
5
Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration

Related stock quotes

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 July 2017 09:48:01
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170720.2 - EUROWEB4 - 2017-07-26 10:48:01 - 2017-07-26 09:48:01 - 1000 - Website: OKAY